help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-1327
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Pantel, J.
Right arrow Articles by Amselem, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pantel, J.
Right arrow Articles by Amselem, S.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 11 4334-4341
Copyright © 2009 by The Endocrine Society

Recessive Isolated Growth Hormone Deficiency and Mutations in the Ghrelin Receptor

Jacques Pantel1, Marie Legendre1, Sylvie Nivot, Séverine Morisset, Marie-Pierre Vie-Luton, Yves le Bouc, Jacques Epelbaum and Serge Amselem

INSERM (J.P., M.L., M.-P.V.-L., S.A.), U933, 75011 Paris, France; Centre Hospitalier Universitaire de Rennes (S.N.), Unité d’Endocrinologie Pédiatrique, 35056 Rennes, France; INSERM (S.M.), U573, 75014 Paris, France; AP-HP (Y.L.B.), Hôpital Armand Trousseau, Service d’Explorations Fonctionnelles Endocriniennes, 75771 Paris, France; and INSERM (J.E.), U549, 75014 Paris, France

Address all correspondence and requests for reprints to: Jacques Pantel, Department of Molecular Physiology and Biophysics, 702 LH Vanderbilt Medical Center, 2215 Garland Avenue, Nashville, Tennessee 37232. E-mail: jacques.pantel{at}vanderbilt.edu.

Context: Both GH releasing- and orexigenic properties of the gut-to-brain hormone ghrelin are mediated by the GH secretagogue receptor (GHSR). Recently in several patients, a missense mutation (p.A204E) resulting in a complete loss of GHSR constitutive activity has been implicated in short stature with dominant transmission.

Objective: The objective of the study was to describe the phenotype associated with partial isolated GH deficiency of a young patient born to unrelated parents and identify the molecular basis of his disease.

Results: The growth delay (–3.0 SD) was associated with recurrent episodes of abdominal pain, vomiting, ketosis, hypoglycemia, and a low body mass index. GHSR sequencing revealed that the patient was compound heterozygous for two new defects: 1) an early occurring transition predicting a premature stop codon (c.6G>A, p.W2X) inherited from his unaffected father, therefore strongly arguing against haploinsufficiency as a disease mechanism, and 2) a missense mutation (c.709A>T, p.R237W) inherited from his healthy mother, involving an evolutionary invariant residue from the third intracellular loop. In vitro experiments showed that the p.R237W mutation would result in a partial loss of constitutive activity of the receptor, whereas both its ability to respond to ghrelin and its cell surface expression are preserved.

Conclusion: These data, which describe the first case of recessive partial isolated GH deficiency due to GHSR mutations and emphasize the physiological importance of the GHSR in somatic growth, are discussed in light of the dominantly expressed p.A204E mutation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society